Entity Type
Individual
Filer Snapshot
Matthew Winton
CIK 0001971400. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total Filings
14
Latest Filing
13 Feb 2026
Industry
n/a
Follow future filing-backed changes
Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next click
Start with the summary below, then verify the strongest source-backed page for this filer.
- Open 13F if you want portfolio holdings.
- Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 13 Feb 2026 for CIK 0001971400.
- Business address
- C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA, 02210
- Top holdings (ownership)
- INZY and CRVO
Filer intelligence
What SEC filings say about Matthew Winton
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for INZY worth $184.7K.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
INZY
01 Jul 2025 · COO
CRVO
11 Feb 2026 · Chief Commercial and Business
Latest update
What changed recently for Matthew Winton
Latest ownership report period: 11 Feb 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
13 Feb 2026
Page type
Ownership filings
Latest period
11 Feb 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 13 Feb 2026.
Filer Overview
Matthew Winton has filed 14 SEC EDGAR filings since 04 Apr 2023. Common forms include 4, 3.
Latest Filings
Recent SEC filings for Matthew Winton with direct links to document and filing folders.
4
File 001-37942
FORM 4
- Filing date
- 13 Feb 2026
- Reporting date
- 11 Feb 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-37942
FORM 4
- Filing date
- 19 Nov 2025
- Reporting date
- 17 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-37942
FORM 4
- Filing date
- 17 Nov 2025
- Reporting date
- 14 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-37942
FORM 4
- Filing date
- 08 Oct 2025
- Reporting date
- 06 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 001-37942
FORM 3
- Filing date
- 08 Oct 2025
- Reporting date
- 06 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 03 Jul 2025
- Reporting date
- 01 Jul 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 27 Jun 2025
- Reporting date
- 25 Jun 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 02 Apr 2025
- Reporting date
- 31 Mar 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 17 Mar 2025
- Reporting date
- 11 Mar 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 03 Oct 2024
- Reporting date
- 30 Sep 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 03 Apr 2024
- Reporting date
- 28 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
4
- Filing date
- 15 Mar 2024
- Reporting date
- 13 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-39397
FORM 4 SUBMISSION
- Filing date
- 04 Apr 2023
- Reporting date
- 03 Apr 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 001-39397
FORM 3 SUBMISSION
- Filing date
- 04 Apr 2023
- Reporting date
- 03 Apr 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
About this filer
Matthew Winton files with the SEC under CIK 0001971400. This page aggregates EDGAR filings and related ownership activity.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.